Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 14,150 KRW
Change Today +200.00 / 1.43%
Volume 48.1K
As of 2:10 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

celltrion pharm inc (068760) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - 23,200
52 Week Low
12/15/14 - 8,000
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CELLTRION PHARM INC (068760)

Related News

No related news articles were found.

celltrion pharm inc (068760) Related Businessweek News

No Related Businessweek News Found

celltrion pharm inc (068760) Details

Celltrion Pharm Inc., a pharmaceutical company, produces and sells biosimilars and over-the-counter drugs in South Korea. It offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotics/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. The company also exports its products to South-East Asian countries, such as China, the Philippines, Vietnam, and Kazakhstan. It serves approximately 3800 customers, including university hospitals and general pharmacies. The company was founded in 1976 and is headquartered in Seoul, South Korea.

Founded in 1976

celltrion pharm inc (068760) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

celltrion pharm inc (068760) Key Developments

Celltrion Pharm Inc. Proposes Changes to the Articles of Incorporation

Celltrion Pharm Inc. proposed changes to the articles of incorporation which will be considered for approval at the AGM to be held on March 26, 2015.

Celltrion Pharm Inc., Annual General Meeting, Mar 26, 2015

Celltrion Pharm Inc., Annual General Meeting, Mar 26, 2015., at 09:00 Korea Standard Time. Location: Eon-ju (Nonhyun) second floor conference room of the Construction Financial Cooperative. Agenda: To approve the group financial statements (separate and consolidated); to approve changes to the articles of incorporation; to approve election of directors; to approve director remuneration; to approve auditor remuneration; and to approve stock option grants.

Celltrion Pharm Inc., Annual General Meeting, Mar 28, 2014

Celltrion Pharm Inc., Annual General Meeting, Mar 28, 2014., at 09:00 Korea Standard Time. Location: 706-1, Yeoksam-dong, Gangnam-gu, Seoul Tower, 6th Floor Kite. Agenda: To approve the Financial Statement; to approve the articles of incorporation to change some; to approve election of Directors; to approve director remuneration; and to approve stock option grants.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
068760:KS 14,150.00 KRW +200.00

068760 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 068760.
View Industry Companies

Industry Analysis


Industry Average

Valuation 068760 Industry Range
Price/Earnings 52.6x
Price/Sales 3.5x
Price/Book 1.1x
Price/Cash Flow 58.2x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLTRION PHARM INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at